Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow Reinvestment Rate
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥652.49 Million (capex CN¥652.49 Million ) from operating cash flow of CN¥1.25 Billion. See Starlake Bioscience Co Inc Zhaoqing Guan free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 25 annual periods. For the full cash flow conversion analysis, see 600866 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year capital reinvestment analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. See 600866 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.16 Billion | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +358.2% |
| 2024 | 0.36x | CN¥873.65 Million | CN¥2.40 Billion | CN¥638.50 Million | ▼ -40.2% |
| 2023 | 0.61x | CN¥1.23 Billion | CN¥2.03 Billion | CN¥375.83 Million | ▲ +26.3% |
| 2022 | 0.48x | CN¥802.34 Million | CN¥1.66 Billion | CN¥452.34 Million | ▼ -57.0% |
| 2021 | 1.12x | CN¥216.26 Million | CN¥192.63 Million | CN¥205.08 Million | ▼ -6.8% |
| 2020 | 1.20x | CN¥301.07 Million | CN¥249.99 Million | CN¥289.89 Million | ▲ +52.3% |
| 2019 | 0.79x | CN¥168.59 Million | CN¥213.17 Million | CN¥157.41 Million | ▲ +16.3% |
| 2018 | 0.68x | CN¥34.46 Million | CN¥50.69 Million | CN¥33.71 Million | ▼ -83.6% |
| 2017 | 4.14x | CN¥165.61 Million | CN¥40.05 Million | CN¥40.61 Million | ▲ +158.8% |
| 2016 | 1.60x | CN¥65.78 Million | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.9% |
| 2015 | 75.72x | CN¥207.87 Million | CN¥2.75 Million | CN¥103.49 Million | ▲ +480.4% |
| 2011 | 13.05x | CN¥859.52 Million | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥396.40 Million | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥62.60 Million | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥49.97 Million | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥74.90 Million | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥77.37 Million | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥69.77 Million | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥220.76 Million | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥110.12 Million | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥88.18 Million | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥77.35 Million | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥67.16 Million | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥79.45 Million | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥113.73 Million | CN¥71.14 Million | CN¥113.73 Million | — |